Business Context and Reporting Period
The filing is Healthcare Trust, Inc.’s unaudited Form 10-Q for the three months ended March 31, 2019. The request metadata identifies National Healthcare Properties, Inc., but the filing registrant is Healthcare Trust, Inc. The company is an externally managed healthcare REIT focused on medical office buildings, triple-net healthcare facilities and seniors housing operating properties.
- Portfolio: 189 properties in 31 states totaling approximately 9.0 million rentable square feet.
- Property mix: 109 medical office buildings, 19 triple-net healthcare facilities, 58 seniors housing operating properties, two land parcels and one development property.
- The company had 92.3 million common shares outstanding at March 31, 2019 and no listed securities or public trading market.
Financial Highlights
| Metric | Q1 2019 | Q1 2018 | Change |
| Revenue from tenants | $88.7 million | $89.4 million | (0.8%) |
| Net loss attributable to stockholders | $5.1 million | $6.0 million | Loss improved by $0.9 million |
| Net loss per share | $0.06 | $0.07 | Improved |
| Operating income before property-sale gain | $3.2 million | $5.3 million | (40.3%) |
| Net operating income | $35.9 million | $36.3 million | (1.1%) |
| FFO attributable to stockholders | $8.8 million | $15.1 million | (41.8%) |
| MFFO attributable to stockholders | $6.9 million | $13.8 million | (50.4%) |
| Cash flow from operating activities | $16.5 million | $16.9 million | (2.4%) |
- Revenue less property operating expense produced a consolidated NOI margin of approximately 40.5%, compared with 40.6% in Q1 2018.
- Operating expenses increased 1.7% to $85.6 million. General and administrative expense rose 72.5% to $6.3 million, primarily from higher professional, audit, transfer-agent, legal and related-party reimbursement costs.
- Interest expense increased 25.0% to $13.9 million as a result of higher interest rates and higher debt balances.
- The company recorded a $6.1 million gain on the sale of five New York medical office buildings. Excluding this gain, operating income declined.
- No impairment charges were recorded in Q1 2019, compared with $0.7 million in Q1 2018.
Balance Sheet, Debt and Liquidity
| Balance-sheet item | March 31, 2019 | December 31, 2018 |
| Total assets | $2.35 billion | $2.38 billion |
| Real estate investments, net | $2.19 billion | $2.17 billion |
| Cash and cash equivalents | $63.5 million | $77.3 million |
| Total liabilities | $1.12 billion | $1.14 billion |
| Total debt, approximately | $1.1 billion | $1.1 billion |
| Total equity | $1.22 billion | $1.24 billion |
- Total debt leverage was approximately 45.0% of total assets; weighted-average debt cost was approximately 4.7%, versus 4.6% at December 31, 2018.
- Debt included $462.4 million of gross mortgage notes, $233.6 million under the new senior secured credit facility and $359.3 million under Fannie Mae master credit facilities.
- The new credit facility, entered into in March 2019, provides total commitments of $630.0 million, including a potential $370.0 million accordion subject to lender approval. At quarter-end, $83.6 million was outstanding on the revolver, $150.0 million on the term loan and $31.6 million of revolver capacity remained available.
- Scheduled mortgage principal payments were $37.9 million for the remainder of 2019 and $24.3 million in 2020. Management planned to refinance or extend mortgages maturing in 2019.
- Operating cash flow covered approximately 85% of cash distributions to common stockholders and OP unit holders; 36% of distributions were funded through DRIP proceeds. Management states that operating cash flow has historically been insufficient to fund all distributions.
- The monthly distribution rate was $0.85 per share annually, or approximately $0.21 per share for the quarter. The new credit facility restricts increases to distributions until no later than January 1, 2020 and imposes additional coverage restrictions thereafter.
Material Changes Versus the Prior Comparable Period
- Completed the acquisition of three multi-tenant medical office buildings for a contract purchase price of $30.2 million, funded with financing proceeds and cash.
- Sold five New York medical office buildings for a contract price of $45.0 million and recognized a $6.1 million gain. One related property remained held for sale at a carrying value of $13.1 million.
- Replaced the prior credit facility with the new $630.0 million senior secured facility and issued a $150.0 million term loan.
- Revenue and consolidated NOI were broadly stable, but triple-net NOI declined 34.0%, primarily because of bad debt and tenant defaults. SHOP NOI declined 4.1% as operating expenses rose faster than revenue. MOB NOI increased 9.2%.
- Interest expense increased $2.8 million, while general and administrative expense increased $2.6 million.
- FFO and MFFO declined materially, reflecting higher interest expense, tenant credit issues and other operating changes.
- The company adopted ASC 842 on January 1, 2019. Adoption resulted in recognition of right-of-use assets and lease liabilities for ground leases and an $87,000 reduction to opening accumulated deficit.
Outlook, Commentary, Risks and Unusual Items
- No quantitative earnings or revenue guidance was provided.
- Management expected to pursue two additional medical office building acquisitions in Pennsylvania for an aggregate contract price of $10.0 million, subject to closing conditions.
- LaSalle tenants at four Texas properties were in default and owed $5.5 million as of March 31, 2019. The entire receivable and related income were reserved. A guarantor subsequently filed for Chapter 11 bankruptcy, and the company was evaluating its remedies.
- NuVista tenants at two Florida properties were in default and owed $10.1 million. The entire receivable and related income were reserved. One Wellington property transitioned to company-selected management after a court order, and the company expected to seek termination of the existing lease and transition the property to a SHOP structure.
- The Jupiter, Florida development remained delayed and had not generated rental income. The company had funded $92.9 million, including $10.9 million above its stated construction funding commitment, and could fund additional amounts. Palm, the developer, was in default and the timing of the certificate of occupancy and replacement tenant remained uncertain.
- Healthcare regulation, tenant credit quality, occupancy, interest-rate movements, refinancing requirements, liquidity constraints and the ability to maintain REIT qualification were identified as significant risks.
- The company is externally managed by affiliates of AR Global and incurred $8.7 million of related-party operating fees and reimbursements during the quarter.
- Subsequent to quarter-end, the company repurchased 656,434 shares for approximately $13.3 million, entered into swaps covering the $150.0 million term loan and repaid $16.7 million of mortgage debt.
- Management reported compliance with applicable debt covenants and effective disclosure controls as of March 31, 2019.
Investor Verification Checklist
- Verify the registrant identity: the supplied filing is for Healthcare Trust, Inc., not National Healthcare Properties, Inc.
- Assess recurring operating performance excluding the $6.1 million property-sale gain and non-cash depreciation adjustments.
- Review tenant-default exposure, reserve adequacy and recovery prospects for LaSalle and NuVista receivables.
- Monitor the Jupiter development’s certificate of occupancy, additional funding needs, replacement-tenant prospects and potential impairment risk.
- Reconcile distributions with operating cash flow, DRIP proceeds and borrowing sources, and evaluate sustainability under the new facility’s distribution restrictions.
- Review near-term mortgage maturities, refinancing or extension execution and variable-rate exposure despite subsequent hedging activity.
- Consider the effect of the $17.50 December 31, 2018 estimated NAV per share, compared with the prior $20.25 estimate, on liquidity and repurchase economics.